Heterogeneity of human tissue‐type plasminogen activator
暂无分享,去创建一个
[1] T. Hunter,et al. Oncogene jun encodes a sequence-specific trans- activator similar to AP-1 , 1988, Nature.
[2] R. Tjian,et al. Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. , 1987, Science.
[3] Deborah L. Higgins,et al. Functional role of proteolytic cleavage at arginine-275 of human tissue plasminogen activator as assessed by site-directed mutagenesis. , 1987, Biochemistry.
[4] T. Harris. Second-generation plasminogen activators. , 1987, Protein engineering.
[5] G. Volckaert,et al. Human tissue-type plasminogen activator gene located near chromosomal breakpoint in myeloproliferative disorder. , 1986, American journal of human genetics.
[6] G. Opdenakker,et al. Influence of Carbohydrate Side Chains on Activity of Tissue-Type Plasminogen Activator , 1986, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[7] R. Eddy,et al. Chromosomal locations of human tissue plasminogen activator and urokinase genes. , 1985, Science.
[8] G. Volckaert,et al. Determination of tissue-type plasminogen-activator mRNA in human and non-human cell lines by dot-blot hybridization. , 1985, The Biochemical journal.
[9] W. Schleuning,et al. Isolation and characterization of the human tissue-type plasminogen activator structural gene including its 5' flanking region. , 1985, The Journal of biological chemistry.
[10] M. Einarsson,et al. Large-scale purification of human tissue-type plasminogen activator using monoclonal antibodies. , 1985, Biochimica et biophysica acta.
[11] S. Latt,et al. Coamplification and coexpression of human tissue-type plasminogen activator and murine dihydrofolate reductase sequences in Chinese hamster ovary cells , 1985, Molecular and cellular biology.
[12] P. Verde,et al. Human urokinase gene is located on the long arm of chromosome 10. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[13] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[14] F. Grosveld,et al. Isolation of a human tissue-type plasminogen-activator genomic DNA clone and its expression in mouse L cells. , 1985, Gene.
[15] J. Kyhse-Andersen. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. , 1984, Journal of biochemical and biophysical methods.
[16] B. Wiman,et al. The Fast Inhibitor of Tissue Plasminogen Activator in Plasma During Pregnancy , 1984, Thrombosis and Haemostasis.
[17] F. Joubert,et al. Purification of human tissue plasminogen activator with Erythrina trypsin inhibitor. , 1984, The Journal of biological chemistry.
[18] P. Verde,et al. Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[19] H. Jörnvall,et al. Tissue plasminogen activator: peptide analyses confirm an indirectly derived amino acid sequence, identify the active site serine residue, establish glycosylation sites, and localize variant differences. , 1984, Biochemistry.
[20] G. Opdenakker,et al. Mechanism of the Stimulatory Effect of Phorbol 12-Myristate 13-Acetate on Cellular Production of Plasminogen Activator , 1984, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[21] H. Jörnvall,et al. Differences between uterine and melanoma forms of tissue plasminogen activator , 1984, FEBS letters.
[22] B. Sobel,et al. Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology. , 1984, Circulation.
[23] J. Zeuthen,et al. Inactive proenzyme to tissue‐type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody. , 1984, The EMBO journal.
[24] E. Levin. Latent tissue plasminogen activator produced by human endothelial cells in culture: evidence for an enzyme-inhibitor complex. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Jörnvall,et al. Purification and characterization of a melanoma cell plasminogen activator. , 1983, European journal of biochemistry.
[26] G. Opdenakker,et al. Effects of 12-O-tetradecanoylphorbol 13-acetate on the production of mRNAs for human tissue-type plasminogen activator. , 1983, European journal of biochemistry.
[27] P. Seeburg,et al. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli , 1983, Nature.
[28] E. Holmgren,et al. Isolation of cDNA sequences coding for a part of human tissue plasminogen activator. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[29] G. Opdenakker,et al. Messenger RNA for human tissue plasminogen activator. , 1982, European journal of biochemistry.
[30] W. Weimar,et al. SPECIFIC LYSIS OF AN ILIOFEMORAL THROMBUS BY ADMINISTRATION OF EXTRINSIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR , 1981, The Lancet.
[31] D. Collen,et al. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture. , 1981, The Journal of biological chemistry.
[32] M. Hoylaerts,et al. Studies on the mechanism of the antifibrinolytic action of tranexamic acid. , 1981, Biochimica et biophysica acta.
[33] D. Rijken,et al. Purification and partial characterization of plasminogen activator from human uterine tissue. , 1979, Biochimica et biophysica acta.
[34] A. Granelli‐Piperno,et al. A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.
[35] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[36] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.